C-TMD IMPACT Vision
To be a premier center for the development of innovative therapies for temporomandibular disorders (TMDs), organized in a “hub-and-spoke” architecture and integrated within the larger TMD IMPACT Collaborative.
What is C-TMD IMPACT?
The Center for TMD IMproving PAtient-Centered Translational Research (C-TMD IMPACT) is a premier center for the development of innovative therapies for temporomandibular disorders (TMDs). By developing the necessary structure to support interdisciplinary research teams, the center will streamline the translational process, facilitate the design of pre-clinical and clinical studies addressing these unmet needs, and promote positive regulatory interactions with the FDA. The first year objectives are listed below:
Objective 1
To develop the multi-institutional infrastructure and operational procedures to complete the launch of C-TMD IMPACT.
Objective 2
To establish strong working relationships with other funded teams that may comprise the Collaborative in the next phase and to work with NIDCR/NIH to define the Collaborative's structure and the roles of each team within the framework.
Objective 3
To enable this translational and 'big data' infrastructure to be put in service of the TMD IMPACT Collaborative by applying our experiences and best practices gleaned from operating C-DOCTOR and FaceBase to C-TMD IMPACT.
C-TMD IMPACT's HUB
Clinical implementation is at the core of C-TMD IMPACT to benefit patients.
Keeping clinical implementation at the heart of the enterprise, C-TMD IMPACT will be organized into three tactical teams: the Pre-Clinical Team, the Clinical Team, and the Translational & Regulatory Science Team. These teams will work in parallel to develop procedures and identify needs in their designated areas, with extensive cross-training, overlap/cross-membership, and communication between teams to ensure a unified approach.
C-TMD IMPACT
The Center for TMD IMproving PAtient-Centered Translational Research (C-TMD IMPACT) is a premier center for the development of innovative therapies for TMDs.
Contact Us
- Yang Chai, Co-PI
- Jianfu Chen, Co-PI
- Bridget Samuels, Operations
- VyVy Nguyen, Operations
C-TMD IMPACT is supported by R34DE033572 from the National Institute of Dental & Craniofacial Research, National Institutes of Health.
The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.